Neurogene Inc. — Earnings Quality Grade C
NGNE · Healthcare
Some red flags
Screening Summary
管理层信号
Financial Trends
Revenue & Net Income ($B)
Margins (%)
18-Point Screening
Revenue Quality
Insufficient data
Insufficient data
Revenue -100.0%, CFFO -9.3%. Cash follows revenue
Expense Quality
No material inventory
CapEx growth 46.4% is >2x revenue growth -100.0%
Insufficient data
Insufficient data
Cash Flow Quality
CFFO/NI = 0.85. Profits backed by cash
FCF is negative ($-0.1B)
Accruals ratio = -4.6%. Low accruals
Cash $0.3B covers debt $0.0B
Balance Sheet Health
No goodwill. Clean balance sheet
Interest coverage = -20665.6x (<2x). Financial stress
Other assets 4.4% vs revenue -100.0%. Normal
No write-off data
Acquisition Risk
FCF after acquisitions negative for 3 years
Small-cap context: A single acquisition on a small balance sheet can trip serial-acquirer logic.
No goodwill
Manipulation Score
Insufficient data
Altman Z-Score
Generated from public financial data using forensic accounting frameworks. Not investment advice. Data: Yahoo Finance · 2026-04-25